RANCHO CORDOVA, Calif., Oct. 31 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today it will report financial results for the fiscal first quarter ended September 30, 2008, on Thursday, November 6, 2008.
Company's Conference Call and Webcast
Management will host a conference call Thursday, November 6, 2008 at 2:00 PM Pacific (5:00 PM Eastern) to review the fiscal first quarter financial results.
The call can be accessed by dialing 1-800-860-2442 within the U.S. or 1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Dr. William Osgood, Chief Executive Officer and Matthew Plavan, Chief Financial Officer will host the call to discuss the first quarter results and other corporate events, followed by a Q&A session. Participants are asked to call the assigned number approximately 5 minutes before the conference call begins.
To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.
A replay of the conference call will be available two hours after the call for the following five business days by dialing 1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S. and entering the following account number when prompted '385107'.
About ThermoGenesis Corp.
ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury.
This press release contains forward-looking statements, and such
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. These statements involve risks
and uncertainties that could cause actual outcomes to differ materially
from those contemplated by the forward-looking statements. Several factors,
including timing of FDA approvals, changes in customer forecasts, our
failure to meet customers' purchase order and quality requirements, supply
shortages, production delays, changes in the markets for customers'
products, introduction timing and acceptance of our new products scheduled
for fiscal year 2009, and introduction of competitive products and other
factors beyond our control, could result in a materially different revenue
outcome and/or in our failure to achieve the revenue levels we expect for
fiscal 2009. A more complete description of these and other risks that
could cause actual events to differ from the outcomes predicted by our
forward-looking statements is set forth under the caption "Risk Factors" in
our annual report on Form 10-K and other reports we file with the
Securities and Exchange Commission from time to time, and you should
consider each of those factors when evaluating the forward-looking
Web site: http://www.thermogenesis.com
Contact: Investor Relations
|SOURCE ThermoGenesis Corp.|
Copyright©2008 PR Newswire.
All rights reserved